Bioventus Inc.
BVS
$8.16
-$0.99-10.82%
| 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -33.54M | -39.48M | -41.96M | -21.65M | -156.23M |
| Total Depreciation and Amortization | 19.14M | 19.07M | 20.63M | 22.14M | 26.82M |
| Total Amortization of Deferred Charges | 5.58M | 6.69M | 6.69M | 6.69M | 6.69M |
| Total Other Non-Cash Items | 59.40M | 51.26M | 49.31M | 25.68M | 141.24M |
| Change in Net Operating Assets | -11.78M | -7.70M | -23.45M | -26.01M | -3.18M |
| Cash from Operations | 38.80M | 29.85M | 11.22M | 6.85M | 15.34M |
| Capital Expenditure | -1.01M | -801.00K | -2.77M | -4.09M | -7.36M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 24.68M | -222.00K | -222.00K | 34.68M | 34.68M |
| Other Investing Activities | -709.00K | -709.00K | -709.00K | -709.00K | -11.51M |
| Cash from Investing | 22.96M | -1.73M | -3.70M | 29.87M | 15.81M |
| Total Debt Issued | -- | 0.00 | 15.00M | 15.00M | 64.00M |
| Total Debt Repaid | -59.58M | -11.32M | -18.32M | -70.32M | -87.26M |
| Issuance of Common Stock | 2.44M | 1.50M | 1.34M | 871.00K | 778.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.56M | -1.92M | -1.89M | -3.83M | -4.17M |
| Cash from Financing | -54.58M | -11.74M | -3.87M | -58.28M | -26.65M |
| Foreign Exchange rate Adjustments | -2.56M | -129.00K | -1.04M | -376.00K | 629.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.62M | 16.25M | 2.61M | -21.93M | 5.13M |
